Washington Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-312
| Closed | -$47.7K | – | 773 |
|
|
2024
Q4 | $47.7K | Hold |
312
| – | – | ﹤0.01% | 446 |
|
|
2024
Q3 | $60.5K | Hold |
312
| – | – | ﹤0.01% | 430 |
|
|
2024
Q2 | $72.3K | Hold |
312
| – | – | ﹤0.01% | 391 |
|
|
2024
Q1 | $67.3K | Hold |
312
| – | – | ﹤0.01% | 412 |
|
|
2023
Q4 | $80.7K | Hold |
312
| – | – | ﹤0.01% | 361 |
|
|
2023
Q3 | $80.2K | Hold |
312
| – | – | ﹤0.01% | 334 |
|
|
2023
Q2 | $88.9K | Hold |
312
| – | – | ﹤0.01% | 336 |
|
|
2023
Q1 | $86.7K | Hold |
312
| – | – | ﹤0.01% | 335 |
|
|
2022
Q4 | $86.4K | Hold |
312
| – | – | ﹤0.01% | 330 |
|
|
2022
Q3 | $83K | Hold |
312
| – | – | ﹤0.01% | 321 |
|
|
2022
Q2 | $64K | Hold |
312
| – | – | ﹤0.01% | 364 |
|
|
2022
Q1 | $66K | Sell |
312
-15
| -5% | -$3.17K | ﹤0.01% | 381 |
|
|
2021
Q4 | $78K | Sell |
327
-102
| -24% | -$24.3K | ﹤0.01% | 368 |
|
|
2021
Q3 | $121K | Buy |
429
+2
| +0.5% | +$564 | ﹤0.01% | 377 |
|
|
2021
Q2 | $148K | Buy |
427
+297
| +228% | +$103K | ﹤0.01% | 352 |
|
|
2021
Q1 | $36K | Buy |
130
+20
| +18% | +$5.54K | ﹤0.01% | 572 |
|
|
2020
Q4 | $27K | Buy |
110
+60
| +120% | +$14.7K | ﹤0.01% | 616 |
|
|
2020
Q3 | $14K | Buy |
50
+35
| +233% | +$9.8K | ﹤0.01% | 670 |
|
|
2020
Q2 | $4K | Sell |
15
-15
| -50% | -$4K | ﹤0.01% | 718 |
|
|
2020
Q1 | $10K | Buy |
+30
| New | +$10K | ﹤0.01% | 661 |
|
|
2018
Q3 | – | Sell |
-255
| Closed | -$74K | – | 290 |
|
|
2018
Q2 | $74K | Buy |
+255
| New | +$74K | ﹤0.01% | 356 |
|